Skip to main content

Currently Skimming:

PublicPrivate Partnership Responses to COVID-19 and Future Pandemics: Proceedings of a Workshop - in Brief
Pages 1-9

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 1...
... pandemic, as well as to explore PPP innovations that are addressing COVID-19 in other countries, to examine PPP pandemic responses that expand the distribution of global public goods, and to discuss PPP pandemic responses that enable the development of a global health security agenda. On June 25, Victor Dzau, president of the National Academy of Medicine, said that globally there are 9.4 million cases of COVID-19 and 480,000 deaths from the disease, with 2.4 million cases and 134,000 deaths in the United States.
From page 2...
... The Africa CDC will help coordinate the COVID-19 Africa Vaccine Clinical Trial Network, which will initiate a vaccine regulatory working group, strengthen systems to vaccinate target populations, and launch a vaccine advocacy campaign. Forum member Jo Ivey Boufford, clinical professor at the New York University School of Global Public Health, asked about the characteristics of sustainable partnerships.
From page 3...
... He suggested that the private sector address security issues around the drug supply and related collateral damage outcomes as the pandemic worsens. Knight added that because a central part of the private sector's current business model involves global travel, the movement of people also needs to be reconsidered to decrease illness transmission.
From page 4...
... To support local communities and COVID-19 interventions, ExxonMobil temporarily shifted select manufacturing lines to the production of oil and gas products to make isopropyl alcohol for hand sanitizer donations. Diara noted that a single sector or entity cannot tackle a major health crisis on its own: the public sector, the private sector, and local communities need to work together within the framework of the International Health Regulations and global health security for effective pandemic readiness and response.
From page 5...
... Elias suggested that effective PPPs in low-resource settings require strengthening primary health care, investing in surveillance, building agile research and development systems, collaborating internationally, funding global public goods, and investing in procurement and delivery. According to Elias, COVID-19 underscores the fact that a nation's health security is inseparable from global health security.
From page 6...
... In its first 3.5 years, CEPI initiated more than 20 programs that focused on 5 target pathogens and 3 rapid response platforms. Some of these rapid response platforms were leveraged at the onset of COVID-19: six projects are testing vaccine response in human subjects, and three more projects will soon enter clinical trials.
From page 7...
... invest in transparency, governance, and accountability mechanisms to build trust and enable long-term engagement. Reflecting on a potential vision for the future, Sturchio quoted WHO's director-general, Tedros Adhanom Ghebreyesus: "Universal health coverage and global health security are two sides of the same coin." He added that in an effort to preserve business continuity and protect employees, their families, and their communities in the event of a global crisis, corporations are beginning to frame sustainability strategies around global health security, with investments in disease prevention, surveillance, and health infrastructure at global, national, and local levels.
From page 8...
... Cameron added that the GHS Index intentionally added a category with broader health system–related indicators so leaders could see the data, understand the relationships between broader access to care and health security, and make better decisions. Lange inquired about possible governance structures for pandemic preparedness and response.
From page 9...
... Lauren Shern, National Academies of Sciences, Engineering, and Medicine, served as the review coordinator. SPONSORS: This workshop was supported by Anheuser-Busch InBev Foundation; Becton, Dickinson and Company; Bill & Melinda Gates Foundation; Catholic Health Association of the United States; ExxonMobil; Johnson & Johnson; Merck & Co., Inc.; Novartis Foundation; PATH; Procter & Gamble Company; Safaricom; United Nations Foundation; University of Notre Dame; UPS Foundation; and U.S.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.